277 related articles for article (PubMed ID: 35689218)
1. An enhanced antioxidant strategy of astaxanthin encapsulated in ROS-responsive nanoparticles for combating cisplatin-induced ototoxicity.
Gu J; Wang X; Chen Y; Xu K; Yu D; Wu H
J Nanobiotechnology; 2022 Jun; 20(1):268. PubMed ID: 35689218
[TBL] [Abstract][Full Text] [Related]
2. Astaxanthin-loaded polymer-lipid hybrid nanoparticles (ATX-LPN): assessment of potential otoprotective effects.
Gu J; Chen Y; Tong L; Wang X; Yu D; Wu H
J Nanobiotechnology; 2020 Mar; 18(1):53. PubMed ID: 32192504
[TBL] [Abstract][Full Text] [Related]
3. A666-conjugated nanoparticles target prestin of outer hair cells preventing cisplatin-induced hearing loss.
Wang X; Chen Y; Tao Y; Gao Y; Yu D; Wu H
Int J Nanomedicine; 2018; 13():7517-7531. PubMed ID: 30532536
[TBL] [Abstract][Full Text] [Related]
4. Evaluating protective and therapeutic effects of alpha-lipoic acid on cisplatin-induced ototoxicity.
Kim KH; Lee B; Kim YR; Kim MA; Ryu N; Jung DJ; Kim UK; Baek JI; Lee KY
Cell Death Dis; 2018 Aug; 9(8):827. PubMed ID: 30068942
[TBL] [Abstract][Full Text] [Related]
5. Protective Effect of Avenanthramide-C on Auditory Hair Cells against Oxidative Stress, Inflammatory Cytokines, and DNA Damage in Cisplatin-Induced Ototoxicity.
Umugire A; Nam YS; Nam YE; Choi YM; Choi SM; Lee S; Cho JH; Cho HH
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769271
[TBL] [Abstract][Full Text] [Related]
6. Dexamethasone-loaded injectable silk-polyethylene glycol hydrogel alleviates cisplatin-induced ototoxicity.
Chen Y; Gu J; Liu J; Tong L; Shi F; Wang X; Wang X; Yu D; Wu H
Int J Nanomedicine; 2019; 14():4211-4227. PubMed ID: 31239676
[No Abstract] [Full Text] [Related]
7. Dual stimuli-responsive and sustained drug delivery NanoSensoGel formulation for prevention of cisplatin-induced ototoxicity.
Thakur NS; Rus I; Sparks E; Agrahari V
J Control Release; 2024 Apr; 368():66-83. PubMed ID: 38331002
[TBL] [Abstract][Full Text] [Related]
8. C-phycocyanin from
Kim YR; Do JM; Kim KH; Stoica AR; Jo SW; Kim UK; Yoon HS
Mar Drugs; 2019 Apr; 17(4):. PubMed ID: 31010222
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of apocynin on cisplatin-induced ototoxicity in an auditory cell line and in zebrafish.
Choi J; Im GJ; Chang J; Chae SW; Lee SH; Kwon SY; Chung AY; Park HC; Jung HH
J Appl Toxicol; 2013 Feb; 33(2):125-33. PubMed ID: 22147442
[TBL] [Abstract][Full Text] [Related]
10. The protective role of ferulic acid against cisplatin-induced ototoxicity.
Jo ER; Youn CK; Jun Y; Cho SI
Int J Pediatr Otorhinolaryngol; 2019 May; 120():30-35. PubMed ID: 30753979
[TBL] [Abstract][Full Text] [Related]
11. ROS-Responsive Nanoparticle as a Berberine Carrier for OHC-Targeted Therapy of Noise-Induced Hearing Loss.
Zhao Z; Han Z; Naveena K; Lei G; Qiu S; Li X; Li T; Shi X; Zhuang W; Li Y; Qiao Y; Liu H
ACS Appl Mater Interfaces; 2021 Feb; 13(6):7102-7114. PubMed ID: 33528239
[TBL] [Abstract][Full Text] [Related]
12. A novel synthetic compound, 3-amino-3-(4-fluoro-phenyl)-1H-quinoline-2,4-dione, inhibits cisplatin-induced hearing loss by the suppression of reactive oxygen species: in vitro and in vivo study.
Shin YS; Song SJ; Kang SU; Hwang HS; Choi JW; Lee BH; Jung YS; Kim CH
Neuroscience; 2013 Mar; 232():1-12. PubMed ID: 23246618
[TBL] [Abstract][Full Text] [Related]
13. Puerarin inhibits cisplatin-induced ototoxicity in mice through regulation of TRPV1-dependent calcium overload.
Lin Y; Liang R; Xie K; Ma T; Zhang J; Xu T; Wang A; Liu S
Biochem Pharmacol; 2024 Feb; 220():115962. PubMed ID: 38043717
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of 1,2,3-triazole derivative KPR-A020 against cisplatin-induced ototoxicity in murine cochlear cultures.
Kim YR; Jung DJ; Oh SK; Lee T; Lee IK; Lee KY; Kim UK
Int J Pediatr Otorhinolaryngol; 2017 May; 96():59-64. PubMed ID: 28390615
[TBL] [Abstract][Full Text] [Related]
15. Protective role of edaravone against cisplatin-induced ototoxicity in an auditory cell line.
Im GJ; Chang J; Lee S; Choi J; Jung HH; Lee HM; Ryu SH; Park SK; Kim JH; Kim HJ
Hear Res; 2015 Dec; 330(Pt A):113-8. PubMed ID: 26278638
[TBL] [Abstract][Full Text] [Related]
16. 5,7-Dihydroxy-4-methylcoumarin modulates the JNK/FoxO1 signaling pathway to attenuate cisplatin-induced ototoxicity by suppressing oxidative stress and apoptosis in vitro.
Li C; Wang X; Qiao X; Fan L; Zhu H; Chen Y; He Y; Zhang Z
Biochim Biophys Acta Mol Cell Res; 2023 Apr; 1870(4):119437. PubMed ID: 36754151
[TBL] [Abstract][Full Text] [Related]
17. Efficiency of antioxidant Avenanthramide-C on high-dose methotrexate-induced ototoxicity in mice.
Umugire A; Choi Y; Lee S; Cho HH
PLoS One; 2022; 17(3):e0266108. PubMed ID: 35353852
[TBL] [Abstract][Full Text] [Related]
18. 20(S)-Ginsenoside Rh1 inhibits cisplatin-induced hearing loss by inhibiting the MAPK signaling pathway and suppressing apoptosis in vitro.
Qiao X; He Y; Li W; Liu C; Yang J; Li H
Biochim Biophys Acta Mol Cell Res; 2023 Jun; 1870(5):119461. PubMed ID: 36931607
[TBL] [Abstract][Full Text] [Related]
19. Protective Effect of Tempol against Cisplatin-Induced Ototoxicity.
Youn CK; Kim J; Jo ER; Oh J; Do NY; Cho SI
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27869744
[TBL] [Abstract][Full Text] [Related]
20. Nrf2 activation protects auditory hair cells from cisplatin-induced ototoxicity independent on mitochondrial ROS production.
Zhang W; Xiong H; Pang J; Su Z; Lai L; Lin H; Jian B; He W; Yang H; Zheng Y
Toxicol Lett; 2020 Oct; 331():1-10. PubMed ID: 32428544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
